Stryker Expands ENT Breadth With $600m-Plus Deal

The orthopedic giant is acquiring Entellus Medical for $24.00 per share, adding to its ear, nose and throat device portfolio with Entellus platforms including XprESS multi-sinus dilation system and the Latera absorbable nasal implant.

Stryker Corp. says it will bring on a set of ENT technologies that are highly complementary to its current offering with the addition of Entellus Medical Inc. to its organization. The large device firm announced on a definitive agreement Dec. 7 to buy Entellus for $24.00 per share, or an equity value of $662m.

Entellus, founded in 2006 in Plymouth, Minn., and traded on the NASDAQ, markets a broad range of ENT devices, including...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business